Article feature image

Taysha Gene Therapies’ (TSHA) CEO RA Session II on Q3 2021 Results – Earnings Call Transcript

Stock Analysis

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2021 Earnings Conference Call November 10, 2021 8:00 AM ET
Company Participants
Kimberly Lee – SVP, Corporate Communications & IR
RA Session II – President, CEO & Founder
Suyash Prasad – CMO & Head, R&D
Kamran…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts